Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Discover credit cards that provide cash rewards without annual fees. Make your spending count!
26,108 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
The 30-year treasury just crossed 5%, triggering a rotation from growth into asset-backed champions. This article fla...
SpaceX and Amazon share a blueprint for infrastructure growth, but their earnings paths diverge, forcing investors to...
Memory industry dynamics are shifting, and Micron stands at the center. This piece breaks down why micron technology ...
Markets are sizing Coca-Cola for a two-year path as AI-driven capital shifts reshape sectors. A fresh price predictio...
Analysts see Amazon approaching a $3 trillion market-cap milestone if AWS growth stays resilient and AI investments m...
A CEO’s share sale at Mineralys shines a light on insider moves ahead of a key FDA event. This guide breaks down what...
A Goldman Sachs AI skeptic warns the market’s patience may be running thin as OpenAI and Anthropic gear up for mega-I...
Tesla is signaling stronger profit margins and robust cash flow, setting up a potential 12% rally in the coming year....
A rising demand for care and resilient cash flow could make a top medical devices firm a lasting anchor for a long-te...
When a legendary investor hands the reins, the next era often comes with bolder bets. This article examines berkshire...
Salesforce faces a mounting private-equity thesis as cash flow and stock discipline collide with high-profile leaders...